| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +75.00% | -8.93% | +0.11% | -9.04% | -7.79% | — |
| 14d | 4 | +100.00% | -6.81% | +0.09% | -6.90% | -7.23% | — |
| 30d | 4 | +75.00% | -6.28% | -0.21% | -6.06% | -10.65% | — |
| 60d | 4 | +75.00% | +42.33% | +6.58% | +35.75% | -22.54% | — |
| 90d | 4 | +75.00% | +51.22% | +8.52% | +42.70% | -36.01% | — |
| 180d | 4(1 pending) | +33.33% | +85.16% | +13.59% | +71.56% | +57.20% | — |
| 1y | 4(1 pending) | +33.33% | +192.82% | +18.18% | +174.64% | -6.34% | — |
| 2y | 4(3 pending) | +0.00% | +119.27% | +29.57% | +89.70% | +89.70% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| CTMX CYTOMX THERAPEUTICS, INC. | SALE SVP, Chief Scientific Officer | 31,492 | $6.42 | $202.3K | 300,760 | Mar 17, 2026 | Mar 19, 2026 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 250,000 | — | — | 250,000 | Feb 2, 2026 | Feb 4, 2026 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 60,000 | — | — | 332,252 | Feb 2, 2026 | Feb 4, 2026 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 18,150 | — | — | 18,150 | Sep 26, 2025 | Sep 30, 2025 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 36,300 | — | — | 36,300 | Sep 26, 2025 | Sep 30, 2025 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | SALE SVP, Chief Scientific Officer | 13,884 | $2.69 | $37.3K | 272,252 | Jun 16, 2025 | Jun 17, 2025 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASE SVP, Chief Scientific Officer | 37,500 | — | — | 286,136 | Jun 13, 2025 | Jun 17, 2025 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | SALE SVP, Chief Scientific Officer | 37,500 | — | — | 0 | Jun 13, 2025 | Jun 17, 2025 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | SALE SVP, Chief Scientific Officer | 19,512 | $0.60 | $11.7K | 248,636 | Mar 18, 2025 | Mar 20, 2025 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 115,000 | — | — | 115,000 | Feb 4, 2025 | Feb 6, 2025 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 57,500 | — | — | 263,148 | Feb 4, 2025 | Feb 6, 2025 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 115,000 | — | — | 115,000 | Feb 4, 2025 | Feb 10, 2025 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 30,000 | — | — | 205,648 | Feb 4, 2025 | Feb 6, 2025 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 140,000 | — | — | 140,000 | Feb 4, 2025 | Feb 6, 2025 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 35,000 | — | — | 210,648 | Feb 4, 2025 | Feb 10, 2025 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 150,000 | — | — | 150,000 | Feb 4, 2025 | Feb 10, 2025 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 57,500 | — | — | 268,148 | Feb 4, 2025 | Feb 10, 2025 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | SALE SVP, Chief Scientific Officer | 11,250 | — | — | 0 | Aug 20, 2024 | Aug 22, 2024 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASE SVP, Chief Scientific Officer | 11,250 | — | — | 179,829 | Aug 20, 2024 | Aug 22, 2024 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | SALE SVP, Chief Scientific Officer | 4,181 | $1.23 | $5.1K | 175,648 | Aug 20, 2024 | Aug 22, 2024 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | SALE SVP, Chief Scientific Officer | 12,795 | $2.09 | $26.7K | 168,579 | Mar 19, 2024 | Mar 21, 2024 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 26,250 | — | — | 181,374 | Jan 18, 2024 | Jan 19, 2024 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 122,500 | — | — | 122,500 | Jan 18, 2024 | Jan 19, 2024 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 75,000 | — | — | 75,000 | Jan 18, 2024 | Jan 19, 2024 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | SALE SVP, Chief Scientific Officer | 4,077 | $1.38 | $5.6K | 155,124 | Dec 20, 2023 | Dec 22, 2023 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASE SVP, Chief Scientific Officer | 11,250 | — | — | 159,201 | Dec 17, 2023 | Dec 19, 2023 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | SALE SVP, Chief Scientific Officer | 11,250 | — | — | 11,250 | Dec 17, 2023 | Dec 19, 2023 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | SALE SVP, Chief Scientific Officer | 4,119 | $1.30 | $5.4K | 147,951 | Sep 22, 2023 | Sep 22, 2023 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 11,250 | — | — | 152,070 | Sep 20, 2023 | Sep 22, 2023 ↗ | View → |
| CTMX CYTOMX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 60,000 | — | — | 140,820 | Mar 22, 2023 | Mar 29, 2023 ↗ | View → |